| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ono-9054 | prostaglandin e2 receptor ep3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Ocular Hypertension[MeSHID:D009798] Glaucoma[MeSHID:D005901] |
1.99 | phase 2 | unknown |
| ono-9054 | prostaglandin f2-alpha receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Ocular Hypertension[MeSHID:D009798] Glaucoma[MeSHID:D005901] |
3.74 | phase 2 | unknown |
| ono-9054 | prostaglandin f2-alpha receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Ocular Hypertension[MeSHID:D009798] Glaucoma[MeSHID:D005901] |
3.74 | phase 2 | agonist |
| click here to return to the previous page | ||||||||